Optimization of microflow LC-MS/MS and its utility in quantitative discovery bioanalysis

Area of Science:

• Analytical Chemistry
• Pharmacology
• Biochemistry

Background:

• Microflow liquid chromatography-tandem mass spectrometry (μFLC-MS/MS) presents a significant sensitivity advantage over conventional flow LC-MS/MS.
• This enhanced sensitivity is crucial for detecting challenging compounds in drug discovery bioanalysis.
• Discovery bioanalytical scientists require effective strategies for μFLC method development and optimization.

Purpose of the Study:

• To develop a systematic approach for μFLC-MS/MS method optimization.
• To evaluate the sensitivity, performance, and robustness of μFLC-MS/MS for drug discovery bioanalysis.
• To demonstrate the universal applicability of optimized μFLC-MS/MS conditions across diverse compounds.

Main Methods:

• A systematic method optimization strategy was employed for μFLC-MS/MS.
• Analytical performance and robustness were assessed under optimized conditions.
• Comparative analysis with conventional LC-MS/MS was conducted.

Main Results:

• Optimized μFLC-MS/MS achieved sensitivity improvements ranging from 6× to 49× (by peak area) compared to conventional LC-MS/MS.
• The method demonstrated acceptable analytical performance and robustness.
• Optimized conditions showed universal applicability for compounds with diverse properties.

Conclusions:

• A systematic method optimization strategy facilitates the routine use of μFLC in quantitative discovery bioanalysis.
• The optimized conditions are broadly applicable, enhancing the utility of μFLC-MS/MS.
• μFLC-MS/MS provides a powerful solution for analyzing challenging compounds in drug discovery.